Synonyms: prostacyclin | prostacyclin I2 | prostaglandin I2 | vasocyclin
PGI2 is an approved drug (FDA (1995))
Compound class:
Metabolite
Comment: PGI2 is an endogenous prostaglandin. Synthetic PGI2 is known as epoprostenol. PG12 activates prostanoid family GPCRs.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖View more information in the IUPHAR Pharmacology Education Project: pgi2 |
|
References |
1. Davis TL, Sharif NA. (2000)
Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor. Br J Pharmacol, 130: 1919-1926. [PMID:10952683] |
2. Sharif NA, Davis TL. (2002)
Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques. J Pharm Pharmacol, 54 (4): 539-47. [PMID:11999132] |
3. Siegl AM, Smith JB, Silver MJ, Nicolaou KC, Ahern D. (1979)
Selective binding site for [3H]prostacyclin on platelets. J Clin Invest, 63 (2): 215-20. [PMID:372237] |